{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:45:06Z","timestamp":1791812706810,"version":"4.3.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016877","name":"Rosztoczy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Eplet mismatch load is a molecular measure of donor\u2013recipient histocompatibility that has been associated with alloimmune outcomes after kidney transplantation. However, its relationship with comprehensive markers of early allograft injury remains incompletely defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center retrospective cohort study, we evaluated 657 adult kidney transplant recipients who underwent transplantation between January 2021 and December 2024. Eplet mismatch load was calculated at the HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci using the HLA Eplet Registry. The primary outcome was a composite of early allograft injury, defined as the independent occurrence of de novo donor-specific antibodies, histologic rejection, molecular rejection assessed by the Molecular Microscope Diagnostic System, or elevation of donor-derived cell-free DNA within the first year after transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the first post-transplant year, 248 patients (37.7%) experienced the primary outcome. Median eplet mismatch load was significantly higher among patients with the primary outcome across most HLA loci. In adjusted Cox regression models, higher eplet mismatch load (per one-eplet increase) was independently associated with increased risk of the primary outcome for HLA-DRB1 (hazard ratio 1.025; 95% confidence interval 1.011\u20131.038), HLA-DQA1 (hazard ratio 1.075; 95% confidence interval 1.025\u20131.127), and HLA-DQB1 (hazard ratio 1.038; 95% confidence interval 1.020\u20131.057). Compared with zero eplet mismatch, high-risk class II eplet mismatch categories were associated with approximately two- to three-fold higher risk of early allograft injury. Associations for class I loci were weaker and pattern-dependent after adjustment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, a higher class II HLA-eplet mismatch load was independently associated with early kidney allograft injury during the first post-transplant year.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag341","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:16:13Z","timestamp":1790424973000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of eplet mismatch load and allograft injury in kidney transplant recipients"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3679-4503","authenticated-orcid":false,"given":"Fruzsina","family":"Toth","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology & Hypertension, Spencer Fox Eccles School of Medicine at the University of Utah , Salt Lake City, UT ,","place":["USA"]},{"name":"Doctoral College, Theoretical and Translational Medicine Division, Semmelweis University , Budapest ,","place":["Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendon J","family":"Holdaway","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology & Hypertension, Spencer Fox Eccles School of Medicine at the University of Utah , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0237-655X","authenticated-orcid":false,"given":"Divya","family":"Raghavan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology & Hypertension, Spencer Fox Eccles School of Medicine at the University of Utah , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silviana","family":"Marineci","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology & Hypertension, Spencer Fox Eccles School of Medicine at the University of Utah , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suayp","family":"Oygen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology & Hypertension, Spencer Fox Eccles School of Medicine at the University of Utah , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Fornadi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Transplantation and Advanced Hepatobiliary Surgery, Spencer Fox Eccles School of Medicine at the University of Utah , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9665-330X","authenticated-orcid":false,"given":"Miklos Z","family":"Molnar","sequence":"additional","affiliation":[{"name":"Transplant Institute, University of Rochester Medical Center , Rochester, NY ,","place":["USA"]},{"name":"Division of Nephrology, Department of Medicine, University of Rochester Medical Center , Rochester, NY ,","place":["USA"]},{"name":"Department of Surgery, University of Rochester Medical Center , Rochester, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"2026101208471813000_bib1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/ajt.15177","article-title":"HLA-DR\/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity","volume":"19","author":"Wiebe","year":"2019","journal-title":"Am J Transplant"},{"key":"2026101208471813000_bib2","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3390\/biomedicines11102741","article-title":"Donor-derived cell-free DNA at 1 month after kidney transplantation relates to HLA class II eplet mismatch load","volume":"11","author":"Gonz\u00e1lez-L\u00f3pez","year":"2023","journal-title":"Biomedicines"},{"key":"2026101208471813000_bib3","doi-asserted-by":"publisher","first-page":"703457","DOI":"10.3389\/fimmu.2021.703457","article-title":"Non-HLA antibodies and epitope mismatches in kidney transplant recipients with histological antibody-mediated rejection","volume":"12","author":"Crespo","year":"2021","journal-title":"Front Immunol"},{"key":"2026101208471813000_bib4","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1038\/s41467-025-60485-y","article-title":"Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allografts","volume":"16","author":"Demir","year":"2025","journal-title":"Nat Commun"},{"key":"2026101208471813000_bib5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.2215\/CJN.00570122","article-title":"Association of HLA mismatches and histology suggestive of antibody-mediated injury in the absence of donor-specific anti-HLA antibodies","volume":"17","author":"Senev","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101208471813000_bib6","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1681\/ASN.2020010019","article-title":"Eplet mismatch load and de novo occurrence of donor-specific anti-HLA antibodies, rejection, and graft failure after kidney transplantation: an observational cohort study","volume":"31","author":"Senev","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2026101208471813000_bib7","doi-asserted-by":"publisher","first-page":"623276","DOI":"10.3389\/fimmu.2020.623276","article-title":"Donor\/recipient HLA molecular mismatch scores predict primary humoral and cellular alloimmunity in kidney transplantation","volume":"11","author":"Meneghini","year":"2020","journal-title":"Front Immunol"},{"key":"2026101208471813000_bib8","doi-asserted-by":"publisher","first-page":"e15748","DOI":"10.1111\/tan.15748","article-title":"Combined molecular mismatch approaches to predict immunological events within the first year after renal transplantation","volume":"104","author":"J\u00e4ger","year":"2024","journal-title":"HLA"},{"key":"2026101208471813000_bib9","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1111\/ajt.14393","article-title":"Donor-recipient matching based on predicted indirectly recognizable HLA epitopes independently predicts the incidence of de novo donor-specific HLA antibodies following renal transplantation","volume":"17","author":"Lachmann","year":"2017","journal-title":"Am J Transplant"},{"key":"2026101208471813000_bib10","doi-asserted-by":"publisher","first-page":"1447141","DOI":"10.3389\/fgene.2024.1447141","article-title":"HLA-DR\/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens","volume":"15","author":"Wong","year":"2024","journal-title":"Front Genet"},{"key":"2026101208471813000_bib11","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.3390\/ijms23137357","article-title":"Combined analysis of HLA class II eplet mismatch and tacrolimus levels for the prediction of de novo donor specific antibody development in kidney transplant recipients","volume":"23","author":"Lee","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026101208471813000_bib12","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1681\/ASN.2017030287","article-title":"Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development","volume":"28","author":"Wiebe","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026101208471813000_bib13","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3389\/fimmu.2020.02000","article-title":"Analysis of T and B cell epitopes to predict the risk of de novo donor-specific antibody (DSA) production after kidney transplantation: a two-center retrospective cohort study","volume":"11","author":"Sakamoto","year":"2020","journal-title":"Front Immunol"},{"key":"2026101208471813000_bib14","doi-asserted-by":"publisher","first-page":"1508796","DOI":"10.3389\/fimmu.2025.1508796","article-title":"De Novo donor-specific anti-HLA antibody risk stratification in kidney transplantation using a combination of B cell and T cell molecular mismatch assessment","volume":"16","author":"Chou-Wu","year":"2025","journal-title":"Front Immunol"},{"key":"2026101208471813000_bib15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/iji.12519","article-title":"HLA class II eplet mismatch load improves prediction of dnDSA development after living donor kidney transplantation","volume":"48","author":"Tafulo","year":"2021","journal-title":"Int J Immunogenetics"},{"key":"2026101208471813000_bib16","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.kint.2018.12.029","article-title":"Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression","volume":"95","author":"Snanoudj","year":"2019","journal-title":"Kidney Int"},{"key":"2026101208471813000_bib17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/tan.15008","article-title":"HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy","volume":"102","author":"Bezstarosti","year":"2023","journal-title":"HLA"},{"key":"2026101208471813000_bib18","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/ndt\/gfad246","article-title":"Early progression of chronic histologic lesions in kidney transplant biopsies is not associated with HLA histocompatibility","volume":"39","author":"Jabbour","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026101208471813000_bib19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.transproceed.2009.12.047","article-title":"Evaluation of HLA matchmaker compatibility as predictor of graft survival and presence of anti-HLA antibodies","volume":"42","author":"Silva","year":"2010","journal-title":"Transplant Proc"},{"key":"2026101208471813000_bib20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.kint.2019.10.028","article-title":"Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss","volume":"97","author":"Sapir-Pichhadze","year":"2020","journal-title":"Kidney Int"},{"key":"2026101208471813000_bib21","doi-asserted-by":"publisher","first-page":"1442018","DOI":"10.3389\/fgene.2024.1442018","article-title":"Improving long-term kidney allograft survival by rethinking HLA compatibility: from molecular matching to non-HLA genes","volume":"15","author":"Mattoo","year":"2024","journal-title":"Front Genet"},{"key":"2026101208471813000_bib22","doi-asserted-by":"publisher","first-page":"e15346","DOI":"10.1111\/tan.15346","article-title":"Determination of the clinical relevance of donor epitope-specific HLA-antibodies in kidney transplantation","volume":"103","author":"Kardol-Hoefnagel","year":"2024","journal-title":"HLA"},{"key":"2026101208471813000_bib23","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant"},{"key":"2026101208471813000_bib24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/ajt.12968","article-title":"HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study","volume":"15","author":"Sapir-Pichhadze","year":"2015","journal-title":"Am J Transplant"},{"key":"2026101208471813000_bib25","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1097\/TP.0000000000002117","article-title":"A comparison of HLA molecular mismatch methods to determine HLA immunogenicity","volume":"102","author":"Wiebe","year":"2018","journal-title":"Transplantation"},{"key":"2026101208471813000_bib26","doi-asserted-by":"publisher","first-page":"e15297","DOI":"10.1111\/tan.15297","article-title":"Ellipro scores of donor epitope specific HLA antibodies are not associated with kidney graft survival","volume":"103","author":"Kardol-Hoefnagel","year":"2024","journal-title":"Hla"},{"key":"2026101208471813000_bib27","doi-asserted-by":"publisher","first-page":"e1905","DOI":"10.1097\/TXD.0000000000001905","article-title":"Early elevations in donor-derived cell-free DNA are associated with increased risk of future rejection and graft dysfunction after kidney transplant","volume":"12","author":"Parajuli","year":"2026","journal-title":"Transplant Direct"},{"key":"2026101208471813000_bib28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the assessing donor-derived cell-free DNA monitoring insights of kidney allografts with longitudinal surveillance (ADMIRAL) study","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"key":"2026101208471813000_bib29","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3389\/ti.2026.15929","article-title":"Longitudinal monitoring of donor-derived cell-free DNA supports risk stratification in kidney transplant recipients with allograft dysfunction","volume":"39","author":"Schr\u00f6ter","year":"2026","journal-title":"Transpl Int"},{"key":"2026101208471813000_bib30","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/frtra.2025.1624291","article-title":"Plasma total and donor-derived cell-free DNA predict survival in kidney transplant recipients","volume":"4","author":"Graver","year":"2025","journal-title":"Front Transplant"},{"key":"2026101208471813000_bib31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.kint.2022.01.012","article-title":"Donor-derived cell-free DNA in kidney transplantation: evolving concepts and potential limitations","volume":"101","author":"Huang","year":"2022","journal-title":"Kidney Int"},{"key":"2026101208471813000_bib32","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/ajt.13707","article-title":"Alloantibody responses after renal transplant failure can be better predicted by donor-recipient HLA amino acid sequence and physicochemical disparities than conventional HLA matching","volume":"16","author":"Kosmoliaptsis","year":"2016","journal-title":"Am J Transplant"},{"key":"2026101208471813000_bib33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/TP.0000000000004624","article-title":"The molecular phenotype of kidney transplants: insights from the MMDx project","volume":"108","author":"Halloran","year":"2024","journal-title":"Transplantation"},{"key":"2026101208471813000_bib34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/iji.12017","article-title":"16th IHIW: a website for antibody-defined HLA epitope registry","volume":"40","author":"Duquesnoy","year":"2013","journal-title":"Int J Immunogenetics"},{"key":"2026101208471813000_bib35","doi-asserted-by":"publisher","first-page":"800946","DOI":"10.3389\/fimmu.2021.800946","article-title":"A comprehensive evaluation of the antibody-verified status of eplets listed in the HLA Epitope Registry","volume":"12","author":"Bezstarosti","year":"2021","journal-title":"Front. Immunol"},{"key":"2026101208471813000_bib36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/tan.12341","article-title":"First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA Epitope Registry","volume":"83","author":"Duquesnoy","year":"2014","journal-title":"Tissue Antigens"},{"key":"2026101208471813000_bib37","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.humimm.2014.09.012","article-title":"First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry","volume":"75","author":"Duquesnoy","year":"2014","journal-title":"Hum Immunol"},{"key":"2026101208471813000_bib38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1373\/jalm.2016.022731","article-title":"biological variation of donor-derived cell-free DNA in renal transplant recipients: clinical implications","volume":"2","author":"Bromberg","year":"2017","journal-title":"J Appl Lab Med"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag341\/71402637\/sfag341.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag341\/71402637\/sfag341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag341\/71402637\/sfag341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:47:27Z","timestamp":1791809247000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag341\/8836579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag341","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,26]]},"article-number":"sfag341"}}